Yanchun Peng

16.5k citations
50 papers · 850 indexed · h-index 15
Topics
Immune Cell Function and Interaction (19 papers)Immunotherapy and Immune Responses (14 papers)T-cell and B-cell Immunology (9 papers)

In The Last Decade

Yanchun Peng

44 papers receiving 837 citations

Peers

Yanchun Peng
Comparison fields: 5 of 85
  • Immunology 523
  • Epidemiology 233
  • Oncology 196
  • Molecular Biology 194
  • Infectious Diseases 128
Replace Mari Strengell with:
Mari Strengell Finland
Koon-Chu Yaiw Sweden
Marie J. Estcourt Australia
Gregory M. Frank United States
SangKon Oh United States
Heather D. Marshall United States
Ines Matos United States
Douglas H. Yamada United States
Geraldine M. O’Connor United States
Ka Yee Fung Australia
Yanchun Peng relative to Mari Strengell Finland Mari Strengell's profile →
Citations per field
00.5×3.5×
Mari Strengell · 1×
Citations per year

Countries citing papers authored by Yanchun Peng

Since Specialization
Citations

This map shows the geographic impact of Yanchun Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanchun Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanchun Peng more than expected).

Fields of papers citing papers by Yanchun Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanchun Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanchun Peng. The network helps show where Yanchun Peng may publish in the future.

Co-authorship network of co-authors of Yanchun Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yanchun Peng. A scholar is included among the top collaborators of Yanchun Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanchun Peng. Yanchun Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 0
5 0
6 4
7 2
8 0
9 2
10 6
11 14
12 60
13 1
14 7
15 32
16 12
17 4
18 50
19 9
20 20

About Yanchun Peng

Yanchun Peng is a scholar working on Immunology, Virology and Critical Care and Intensive Care Medicine, having authored 50 papers that have together received 850 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (19 papers), Immunotherapy and Immune Responses (14 papers) and T-cell and B-cell Immunology (9 papers). The work is most often cited by research in Immunology (523 citations), Virology (93 citations) and Oncology (196 citations). Yanchun Peng has collaborated with scholars based in China, United Kingdom and Australia. Frequent co-authors include Tao Dong, Andrew J. McMichael, Yonghong Zhang, Huiping Yan, Dayan Wang, Ling‐Pei Ho, Yuelong Shu, Yan Zhao, Paul Kellam and Ning Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026